Insider · CIK 0001700659

PAKOLA STEVE

Reports to the SEC for 2 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001700659

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−7,468 sh	$9.69	−$72.4K	205,541
2026-07-02	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,161 sh	$7.86	+$17K	215,170
2026-07-02	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−2,161 sh	$13.64	−$29.5K	213,009
2026-07-02	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,161 sh	—	—	64,812
2026-07-01	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+36.7K sh	$7.86	+$289K	249,734
2026-07-01	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−36.7K sh	$12.86	−$472K	213,009
2026-07-01	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−36.7K sh	—	—	66,973
2026-06-29	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−19.6K sh	$11.04	−$216K	213,009
2026-05-11	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−15.3K sh	$11.02	−$169K	232,617
2026-03-10	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−5,124 sh	$10.35	−$53K	247,926
2026-02-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−5,267 sh	$11.16	−$58.8K	253,050
2026-01-06	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+65.8K sh	—	—	258,317
2026-01-06	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+35.4K sh	—	—	35,402
2026-01-02	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−18.2K sh	$14.40	−$263K	192,470
2025-02-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−5,263 sh	$8.07	−$42.5K	210,717
2025-01-02	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−13.9K sh	$7.73	−$107K	151,687
2025-01-02	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+64.3K sh	—	—	215,980
2025-01-02	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+104K sh	—	—	103,698
2024-08-01	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+58.4K sh	—	—	165,578
2024-03-05	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12.9K sh	$22.25	+$287K	120,070
2024-03-05	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−12.9K sh	$28.36	−$365K	107,192
2024-03-05	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.9K sh	—	—	31,277
2024-01-03	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−17.2K sh	$17.39	−$300K	107,192
2024-01-02	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−10.4K sh	$17.95	−$186K	92,378
2024-01-02	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+32.1K sh	—	—	124,429
2024-01-02	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+50.9K sh	—	—	50,875
2023-01-03	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−1,837 sh	$22.68	−$41.7K	15,313
2023-01-03	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−3,138 sh	$22.17	−$69.6K	12,175
2023-01-03	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+90.6K sh	—	—	102,763
2023-01-03	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+44.2K sh	—	—	44,155
2022-01-03	RGNXREGENXBIO Inc.S Sale	Chief Medical Officer	SSale	−1,598 sh	$33.75	−$53.9K	8,250
2022-01-03	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+8,900 sh	—	—	17,150
2022-01-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+42.5K sh	—	—	42,500
2022-01-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−1,152 sh	$32.70	−$37.7K	9,848
2021-01-04	RGNXREGENXBIO Inc.A Award	Chief Medical Officer	AAward	+11K sh	—	—	11,000
2021-01-04	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+49.7K sh	—	—	49,700
2020-01-02	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+42.6K sh	—	—	42,600
2019-04-17	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+95K sh	—	—	95,000
2019-02-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	125,000
2018-04-23	WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Aug 44
PAKOLA STEVE0001700659-26-000016
SEC(opens sec.gov)
Jul 64
PAKOLA STEVE0001700659-26-000014
SEC(opens sec.gov)
Jul 14
PAKOLA STEVE0001700659-26-000012
SEC(opens sec.gov)
May 134
PAKOLA STEVE0001700659-26-000010
SEC(opens sec.gov)
Mar 124
PAKOLA STEVE0001700659-26-000008
SEC(opens sec.gov)
Feb 34
PAKOLA STEVE0001700659-26-000006
SEC(opens sec.gov)
Jan 84
PAKOLA STEVE0001700659-26-000004
SEC(opens sec.gov)
Jan 64
PAKOLA STEVE0001700659-26-000003
SEC(opens sec.gov)
Apr 44
PAKOLA STEVE0001562180-25-003009
SEC(opens sec.gov)
Jan 64
PAKOLA STEVE0001562180-25-000190
SEC(opens sec.gov)
Aug 54
PAKOLA STEVE0001562180-24-006017
SEC(opens sec.gov)
Mar 74
PAKOLA STEVE0001562180-24-002430
SEC(opens sec.gov)

Companies

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850